[e-mail]

ChemGenex: Late Stage Pipeline Is Undervalued

Here's the problem with Chemgenex, Omacetaxine isn't a very good drug. The durability of response is weak, sales potential is minor and its not a lock to be appoved. Chemgenex stock may be overvalued if anything.